196 related articles for article (PubMed ID: 21515687)
1. Studies on lactoferricin-derived Escherichia coli membrane-active peptides reveal differences in the mechanism of N-acylated versus nonacylated peptides.
Zweytick D; Deutsch G; Andrä J; Blondelle SE; Vollmer E; Jerala R; Lohner K
J Biol Chem; 2011 Jun; 286(24):21266-76. PubMed ID: 21515687
[TBL] [Abstract][Full Text] [Related]
2. N-acylated peptides derived from human lactoferricin perturb organization of cardiolipin and phosphatidylethanolamine in cell membranes and induce defects in Escherichia coli cell division.
Zweytick D; Japelj B; Mileykovskaya E; Zorko M; Dowhan W; Blondelle SE; Riedl S; Jerala R; Lohner K
PLoS One; 2014; 9(3):e90228. PubMed ID: 24595074
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of endotoxin neutralization by coupling of a C12-alkyl chain to a lactoferricin-derived peptide.
Andrä J; Lohner K; Blondelle SE; Jerala R; Moriyon I; Koch MH; Garidel P; Brandenburg K
Biochem J; 2005 Jan; 385(Pt 1):135-43. PubMed ID: 15344905
[TBL] [Abstract][Full Text] [Related]
4. Comparing bacterial membrane interactions and antimicrobial activity of porcine lactoferricin-derived peptides.
Han FF; Gao YH; Luan C; Xie YG; Liu YF; Wang YZ
J Dairy Sci; 2013 Jun; 96(6):3471-87. PubMed ID: 23567049
[TBL] [Abstract][Full Text] [Related]
5. Dual mechanism of bacterial lethality for a cationic sequence-random copolymer that mimics host-defense antimicrobial peptides.
Epand RF; Mowery BP; Lee SE; Stahl SS; Lehrer RI; Gellman SH; Epand RM
J Mol Biol; 2008 May; 379(1):38-50. PubMed ID: 18440552
[TBL] [Abstract][Full Text] [Related]
6. Lipid interactions of acylated tryptophan-methylated lactoferricin peptides by solid-state NMR.
Greathouse D; Vostrikov V; McClellan N; Chipollini J; Lay J; Liyanage R; Ladd T
J Pept Sci; 2008 Oct; 14(10):1103-10. PubMed ID: 18523968
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of synthetic cationic peptides and lipopeptides derived from human lactoferricin against Pseudomonas aeruginosa planktonic cultures and biofilms.
Sánchez-Gómez S; Ferrer-Espada R; Stewart PS; Pitts B; Lohner K; Martínez de Tejada G
BMC Microbiol; 2015 Jul; 15():137. PubMed ID: 26149536
[TBL] [Abstract][Full Text] [Related]
8. Influence of N-acylation of a peptide derived from human lactoferricin on membrane selectivity.
Zweytick D; Pabst G; Abuja PM; Jilek A; Blondelle SE; Andrä J; Jerala R; Monreal D; Martinez de Tejada G; Lohner K
Biochim Biophys Acta; 2006 Sep; 1758(9):1426-35. PubMed ID: 16616888
[TBL] [Abstract][Full Text] [Related]
9. Membrane curvature stress and antibacterial activity of lactoferricin derivatives.
Zweytick D; Tumer S; Blondelle SE; Lohner K
Biochem Biophys Res Commun; 2008 May; 369(2):395-400. PubMed ID: 18282464
[TBL] [Abstract][Full Text] [Related]
10. Cyclic antimicrobial R-, W-rich peptides: the role of peptide structure and E. coli outer and inner membranes in activity and the mode of action.
Junkes C; Harvey RD; Bruce KD; Dölling R; Bagheri M; Dathe M
Eur Biophys J; 2011 Apr; 40(4):515-28. PubMed ID: 21286704
[TBL] [Abstract][Full Text] [Related]
11. Membrane potential is vital for rapid permeabilization of plasma membranes and lipid bilayers by the antimicrobial peptide lactoferricin B.
Hossain F; Moghal MMR; Islam MZ; Moniruzzaman M; Yamazaki M
J Biol Chem; 2019 Jul; 294(27):10449-10462. PubMed ID: 31118274
[TBL] [Abstract][Full Text] [Related]
12. Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity.
Farnaud S; Spiller C; Moriarty LC; Patel A; Gant V; Odell EW; Evans RW
FEMS Microbiol Lett; 2004 Apr; 233(2):193-9. PubMed ID: 15063486
[TBL] [Abstract][Full Text] [Related]
13. Membrane binding of an acyl-lactoferricin B antimicrobial peptide from solid-state NMR experiments and molecular dynamics simulations.
Romo TD; Bradney LA; Greathouse DV; Grossfield A
Biochim Biophys Acta; 2011 Aug; 1808(8):2019-30. PubMed ID: 21477580
[TBL] [Abstract][Full Text] [Related]
14. Interaction of a novel antimicrobial peptide isolated from the venom of solitary bee Colletes daviesanus with phospholipid vesicles and Escherichia coli cells.
Čujová S; Bednárová L; Slaninová J; Straka J; Čeřovský V
J Pept Sci; 2014 Nov; 20(11):885-95. PubMed ID: 25123582
[TBL] [Abstract][Full Text] [Related]
15. Interaction studies of novel cell selective antimicrobial peptides with model membranes and E. coli ATCC 11775.
Joshi S; Bisht GS; Rawat DS; Kumar A; Kumar R; Maiti S; Pasha S
Biochim Biophys Acta; 2010 Oct; 1798(10):1864-75. PubMed ID: 20599694
[TBL] [Abstract][Full Text] [Related]
16. Membrane interaction of Escherichia coli hemolysin: flotation and insertion-dependent labeling by phospholipid vesicles.
Hyland C; Vuillard L; Hughes C; Koronakis V
J Bacteriol; 2001 Sep; 183(18):5364-70. PubMed ID: 11514521
[TBL] [Abstract][Full Text] [Related]
17. Structural and biophysical characterization of an antimicrobial peptide chimera comprised of lactoferricin and lactoferrampin.
Haney EF; Nazmi K; Bolscher JG; Vogel HJ
Biochim Biophys Acta; 2012 Mar; 1818(3):762-75. PubMed ID: 22155682
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructural effects of antimicrobial peptides from bovine lactoferrin on the membranes of Candida albicans and Escherichia coli.
van der Kraan MI; van Marle J; Nazmi K; Groenink J; van 't Hof W; Veerman EC; Bolscher JG; Nieuw Amerongen AV
Peptides; 2005 Sep; 26(9):1537-42. PubMed ID: 16112390
[TBL] [Abstract][Full Text] [Related]
19. Blood Compatibility-An Important but Often Forgotten Aspect of the Characterization of Antimicrobial Peptides for Clinical Application.
Harm S; Lohner K; Fichtinger U; Schildböck C; Zottl J; Hartmann J
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31683553
[TBL] [Abstract][Full Text] [Related]
20. Interaction of MreB-derived antimicrobial peptides with membranes.
Saikia K; Chaudhary N
Biochem Biophys Res Commun; 2018 Mar; 498(1):58-63. PubMed ID: 29481806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
